Aagami Consutling

Aagami, Inc.
LifeSciences Catalyst

Strategic Consulting Services

Confidential © Aagami Inc. - May 2010

Aagami, Inc.

A life sciences services company based in suburbs
of Chicago, offers
 Strategic Consulting Services
 Drug Development Services
 Phase I to Phase IV clinical studies
 BA, BE and PK/PD studies
 Technology Licensing Services

Confidential Life Sciences Catalyst © Aagami Inc.- May 2010

Strategic Consulting Services
Investments to and from India
In-Licensing or Out-Licensing
Mergers & Acquisitions targets

Finding the Right
 JV partners and/or Distributors
 CRO and CRAMS providers
 Contract Sales/Marketing companies
 Contract Manufacturing companies


Needs of Mid and Small US firms

 Investments for product development
 Partnerships for co-development and
marketing

 Cost effective Service providers for
product Development and Manufacturing
 Contract Sales and Marketing companies


Indian Industry Snapshot
 4th Largest Pharma market (by volume)
 Top 100 companies are present in 50+ countries
 Top 20 have presence in Regulated markets
 Globally successful in Generics
 Looking to differentiate generic portfolio
 Developing Innovative products portfolio
 Increasingly seeking global market share
Therefore, hungry to acquire companies and
technologies globally, especially in regulated
markets

Indian Firms are targeting

Acquisitions for
 Innovative compounds and technologies
 Companies in Regulated markets
 Novel Drug Delivery Systems


Indian Service Providers bring
 Quality Services for FDA Approvals:
 GCP, GLP & GMP (as per US-FDA standards)
 Largest # USFDA Approved GMP facilities
 Highest # of DMF filings

 Speedier Development Processes:
 Large number of Experienced Scientists
Well established and mature Industry

 Cost Effective Solutions:
 PPP with US is 1:5 – As per World Bank
Easy availability of skilled human resources


Aagami brings

Extensive Experience in the US Biotech,
Pharmaceutical and Medical Device industry
Understanding of ways of working (business
culture) & Deal experience with Indian industry
Extensive network with top 100 Indian LS
companies at CXO levels
Global Licensing and Investing Experience


Sample list of assignments
 Finding partner to manufacture Peptides for a EU conglomerate
 In-Licensing Oncology and Immunology NCEs for the pioneer
of Biotech
 Out-Licensing and Investing in a Intranasal Drug Delivery
Device company from West coast of US
 Licensing Bioavailability enhancers for a CA company
 Strategic Investment in or Licensing the Oral Controlled Release
technology of a CT company
 Strategic Investments in an Ophthalmic Medical Device of a
Mid-West company; Term sheet signed
 Licensing for a new dermatology delivery system, applicable to
both pharmaceutical and personal care products.
 Licensing and Investment for a Southern US company with GI
safe NSAIDs


Sample List of Clients
 Solvay Organics
 Penwest Pharmaceuticals
 Aegis Therapeutics
 ScyFIX
 Agile Therapeutics
 Kurve Technologies
 The pioneer of Biotech
 Phosphagenics
 PLx Pharma

How we do it

 Dedicated promotion
 Small retainer fee
 Success fee based on the Lehman’s


Key people
Dinesh Jain
A business leader in Science and technology industry for over 26 years with
global experience in starting and managing several technology companies.
Has held positions of CEO, President, Vice President. Is a prolific
entrepreneur, Board member and speaker at international business
conferences. Has executed several dozen international deals in 3 continents.
Mahendra Shah
A veteran Scientific leader of 41 years in Bio-Pharmaceutical field. After his
PhD, he has worked with some of the top notch companies like Bristol,
Squibb, Schering, Lyphomed, Fujisawa. Mahendra has been an active Investor
in BioPharmaceutical field and is on the Board of several companies across
the country. At present he is CEO of Next Wave Pharmaceuticals.
Shridhar Andurkar
Chair and Associate Professor of Pharmaceutical sciences at Midwestern
University, Chicago College of Pharmacy, is a Ph D from Auburn University
in Medicinal Chemistry, Conducted postdoctoral research at the University of
Houston. Dr. Andurkar has published numerous papers and made several
presentations in this field. He holds a US patent in the area of anticonvulsant
drugs. Is on the advisory boards of several companies.


Enabling Strategic Partnerships

Aagami, Inc.
2020 Calamos Ct, Suite 209
Naperville, IL 60564
Phone: (630) 799-1572
dinesh@aagami.net
www.aagami.net


Aagami Consutling

Recommandé

Recommandé

Contenu connexe

Tendances

Tendances (18)

Similaire à Aagami Consutling

Similaire à Aagami Consutling (20)

Plus de Aagami, Inc.

Plus de Aagami, Inc. (15)

Aagami Consutling